ÂÜÀòÂÒÂ×

Srihari Narasimhan is an experienced executive in the biotechnology and pharmaceutical sectors, currently serving as Executive Director and Chief of Staff to the CFO at Gilead Sciences since 2020. Srihari has previously held senior leadership roles at Gilead, including Senior Director of Corporate Strategy and Senior Director of Global Commercial. Prior experience includes integral positions at Genentech, Biogen Idec, and ZS Associates, contributing to market planning, strategy development, and project management across various therapeutic areas. Srihari holds advanced degrees in Electrical Engineering from the University of Pennsylvania and has completed multiple business strategy and finance courses from prestigious institutions, including The Wharton School and Yale School of Management. Additionally, Srihari advises various startups in the healthcare sector and serves on the advisory board for the Strategic AI Program at the University of San Francisco.